JP2015531597A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531597A5
JP2015531597A5 JP2015528372A JP2015528372A JP2015531597A5 JP 2015531597 A5 JP2015531597 A5 JP 2015531597A5 JP 2015528372 A JP2015528372 A JP 2015528372A JP 2015528372 A JP2015528372 A JP 2015528372A JP 2015531597 A5 JP2015531597 A5 JP 2015531597A5
Authority
JP
Japan
Prior art keywords
protein
amino acid
acid sequence
seq
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528372A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531597A (ja
JP6073038B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2012/006680 external-priority patent/WO2014030780A1/en
Publication of JP2015531597A publication Critical patent/JP2015531597A/ja
Publication of JP2015531597A5 publication Critical patent/JP2015531597A5/ja
Application granted granted Critical
Publication of JP6073038B2 publication Critical patent/JP6073038B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528372A 2012-08-22 2012-08-22 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用 Active JP6073038B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2012/006680 WO2014030780A1 (en) 2012-08-22 2012-08-22 Screening and engineering method of super-stable immunoglobulin variable domains and their uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016154209A Division JP6293829B2 (ja) 2016-08-05 2016-08-05 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用

Publications (3)

Publication Number Publication Date
JP2015531597A JP2015531597A (ja) 2015-11-05
JP2015531597A5 true JP2015531597A5 (cg-RX-API-DMAC7.html) 2016-09-29
JP6073038B2 JP6073038B2 (ja) 2017-02-01

Family

ID=50150075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528372A Active JP6073038B2 (ja) 2012-08-22 2012-08-22 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用

Country Status (6)

Country Link
US (1) US10078085B2 (cg-RX-API-DMAC7.html)
EP (2) EP2888367B1 (cg-RX-API-DMAC7.html)
JP (1) JP6073038B2 (cg-RX-API-DMAC7.html)
KR (2) KR101796689B1 (cg-RX-API-DMAC7.html)
CN (3) CN113234142B (cg-RX-API-DMAC7.html)
WO (1) WO2014030780A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234142B (zh) * 2012-08-22 2024-03-05 财团法人牧岩生命工学研究所 超稳定免疫球蛋白可变结构域的筛选和改造方法及其应用
HRP20201914T1 (hr) 2013-05-06 2021-01-22 Scholar Rock, Inc. Sastavi i postupci za modulaciju faktora rasta
GB201419899D0 (en) 2014-11-07 2014-12-24 Univ Kent Canterbury Biopharmaceutical production method
MX2017006167A (es) 2014-11-12 2018-03-23 Siamab Therapeutics Inc Compuestos que interactúan con glicanos y métodos de uso.
KR101692629B1 (ko) * 2015-07-14 2017-01-03 계명대학교 산학협력단 매시브 플래카드 제어 장치 및 그 방법
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
EP3452516A4 (en) * 2016-05-04 2019-11-27 Abilita Bio, Inc. Methods and platform for preparing multispanning membrane proteins
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법
EP3459968A1 (en) * 2017-09-20 2019-03-27 Numab Innovation AG Novel stable antibody variable domain framework combinations
WO2019066435A2 (ko) * 2017-09-29 2019-04-04 재단법인 목암생명과학연구소 Bcma에 높은 친화도를 가지는 항-bcma 항체 및 이를 포함하는 암 치료용 약학적 조성물
KR102115300B1 (ko) 2018-06-01 2020-05-26 재단법인 목암생명과학연구소 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법
CN108893487A (zh) * 2018-07-19 2018-11-27 中国农业科学院北京畜牧兽医研究所 一种含有C-Myc蛋白融合标签的植物表达质粒载体及其载体的构建方法
AU2019408420B2 (en) * 2018-12-21 2025-04-17 Vib Vzw Fusion protein with a toxin and scaffold protein

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960007784B1 (ko) 1993-07-02 1996-06-12 포항종합제철 주식회사 일산화탄소(co)가스 센서 및 그 제조방법
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
EP1137664A2 (en) * 1998-12-10 2001-10-04 Washington University Protein transduction system and methods of use thereof
EP1214352A2 (en) 1999-09-07 2002-06-19 Viventia Biotech Inc. Enhanced phage display libraries of human vh fragments and methods for producing same
ES2376454T3 (es) 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
JP2005289809A (ja) * 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
CN102093477B (zh) * 2002-05-22 2014-02-26 艾斯巴技术-诺华有限责任公司 在胞内环境中表现出增强的稳定性的免疫球蛋白构架及其鉴定方法
NZ540194A (en) * 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
GB0226729D0 (en) 2002-11-15 2002-12-24 Medical Res Council Intracellular antibodies
EP1644416A4 (en) 2003-06-30 2007-08-29 Centocor Inc ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
UA89481C2 (uk) * 2003-09-30 2010-02-10 Центокор, Инк. Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
EP1786463A4 (en) * 2004-03-26 2009-05-20 Human Genome Sciences Inc ANTIBODY AGAINST NOGO RECEPTOR
ES2377979T3 (es) * 2004-09-03 2012-04-03 Genentech, Inc. Antagonistas anti-beta7 humanizados y utilizaciones para los mismos
US20070026012A1 (en) * 2005-08-01 2007-02-01 Cornell Research Foundation, Inc. Compositions and methods for monitoring and altering protein folding and solubility
US9150850B2 (en) 2005-08-22 2015-10-06 Cornell Research Foundation, Inc. Compositions and methods for analyzing protein interactions
BRPI0710572A2 (pt) 2006-01-24 2013-01-08 Domantis Limited ligante, uso do ligante, mÉtodos para o tratamento de uma doenÇa alÉrgica, de asma e de cÂncer, para a inibiÇço de uma resposta imune do tipo th2, e administraÇço de tratamento anti-il-4 e tratamento anti-il-13, composiÇço farmacÊutica, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodos para a produÇço de um ligante e de inibiÇço da proliferaÇço de cÉlulas
KR100981356B1 (ko) * 2006-01-31 2010-09-14 대한민국 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법
EP2016101A2 (en) 2006-05-09 2009-01-21 Genentech, Inc. Binding polypeptides with optimized scaffolds
WO2008112640A2 (en) * 2007-03-09 2008-09-18 Sinomab Bioscience Limited Construction and use of a functionally human antibody library with maximized repertoire diversity
CA2691109A1 (en) 2007-06-18 2008-12-24 Kai Bao Tat signal peptides for producing proteins in prokaryotes
EP2238165B1 (en) 2008-01-07 2017-07-05 Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Anti-hiv domain antibodies and method of making and using same
RU2013139260A (ru) * 2011-01-28 2015-03-10 Нэшнл Рисеч Каунсил Оф Канада Конструирование иммуноглобулиновых доменов
CN113234142B (zh) * 2012-08-22 2024-03-05 财团法人牧岩生命工学研究所 超稳定免疫球蛋白可变结构域的筛选和改造方法及其应用

Similar Documents

Publication Publication Date Title
JP6073038B2 (ja) 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用
JP5797642B2 (ja) 合成ポリペプチドライブラリーおよび天然で多様化されたポリペプチドバリアントを作製するための方法
JP6253986B2 (ja) コレクション及びその使用方法
US20260071204A1 (en) Integrated system for library construction, affinity binder screening and expression thereof
CN107513104A (zh) 免疫球蛋白结构域的工程改造
JP2021531822A (ja) 抗体の開発可能性が最大化された抗体ライブラリー
US20250020659A1 (en) Single domain antibody libraries with maximized antibody developability characteristics
KR102216032B1 (ko) 합성 항체 라이브러리의 생성 방법, 상기 라이브러리 및 그 적용(들)
JP6293829B2 (ja) 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用
Leow et al. Monoclonal IgY antibodies
HK40051447A (en) Screening and engineering method of super-stable immunoglobulin variable domains and their uses
CN119591716B (zh) 一种结合人CD8β的VHH及其应用
US20250019460A1 (en) Peptide having framework sequence for random region placement and peptide library composed of said peptide
HK40051447B (en) Screening and engineering method of super-stable immunoglobulin variable domains and their uses
WO2025154793A1 (ja) 多重特異性抗体の製造に使用するための共通のl鎖を同定する方法
JP2023552397A (ja) 可変重鎖のみのライブラリ、その調製方法、及びその使用
Seo Development of high throughput screening systems for the efficient production of antibody fragments in Escherichia coli
Tiller Synthetic Antibodies